A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders

Omar M.A. El-Agnaf; Katerina E. Paleologou; Brett Greer; Abdulmawala M. Abogrein; Jenny E. King; Sultan A. Salem; Nigel J. Fullwood; Fiona E. Benson; Rebecca Hewitt; Kirstie J. Ford; Francis I. Martin; Patrick Harriott; Mark R. Cookson; David Allsop

doi:10.1096/fj.03-1346fje

A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders

Omar M.A. El-Agnaf^*
, Katerina E. Paleologou
, Brett Greer
, Abdulmawala M. Abogrein
, Jenny E. King
, Sultan A. Salem
, Nigel J. Fullwood
, Fiona E. Benson
, Rebecca Hewitt
, Kirstie J. Ford
, Francis I. Martin
, Patrick Harriott
, Mark R. Cookson
, David Allsop

^*Corresponding author for this work

Lancaster University
Queen's University Belfast
National Institutes of Health

Research output: Contribution to journal › Article › peer-review

185 Citations (Scopus)

Original language	English
Pages (from-to)	1315-1317
Number of pages	3
Journal	FASEB Journal
Volume	18
Issue number	11
DOIs	https://doi.org/10.1096/fj.03-1346fje
Publication status	Published - Aug 2004
Externally published	Yes

Access to Document

10.1096/fj.03-1346fje

Cite this

El-Agnaf, O. M. A., Paleologou, K. E., Greer, B., Abogrein, A. M., King, J. E., Salem, S. A., Fullwood, N. J., Benson, F. E., Hewitt, R., Ford, K. J., Martin, F. I., Harriott, P., Cookson, M. R., & Allsop, D. (2004). A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. FASEB Journal, 18(11), 1315-1317. https://doi.org/10.1096/fj.03-1346fje

@article{52a109962f6849d59ccd2c090fcfcd7e,

title = "A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders",

author = "El-Agnaf, \{Omar M.A.\} and Paleologou, \{Katerina E.\} and Brett Greer and Abogrein, \{Abdulmawala M.\} and King, \{Jenny E.\} and Salem, \{Sultan A.\} and Fullwood, \{Nigel J.\} and Benson, \{Fiona E.\} and Rebecca Hewitt and Ford, \{Kirstie J.\} and Martin, \{Francis I.\} and Patrick Harriott and Cookson, \{Mark R.\} and David Allsop",

year = "2004",

month = aug,

doi = "10.1096/fj.03-1346fje",

language = "English",

volume = "18",

pages = "1315--1317",

journal = "FASEB Journal",

issn = "0892-6638",

publisher = "John Wiley \& Sons Inc.",

number = "11",

}

El-Agnaf, OMA, Paleologou, KE, Greer, B, Abogrein, AM, King, JE, Salem, SA, Fullwood, NJ, Benson, FE, Hewitt, R, Ford, KJ, Martin, FI, Harriott, P, Cookson, MR & Allsop, D 2004, 'A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders', FASEB Journal, vol. 18, no. 11, pp. 1315-1317. https://doi.org/10.1096/fj.03-1346fje

TY - JOUR

T1 - A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders

AU - El-Agnaf, Omar M.A.

AU - Paleologou, Katerina E.

AU - Greer, Brett

AU - Abogrein, Abdulmawala M.

AU - King, Jenny E.

AU - Salem, Sultan A.

AU - Fullwood, Nigel J.

AU - Benson, Fiona E.

AU - Hewitt, Rebecca

AU - Ford, Kirstie J.

AU - Martin, Francis I.

AU - Harriott, Patrick

AU - Cookson, Mark R.

AU - Allsop, David

PY - 2004/8

Y1 - 2004/8

UR - https://www.scopus.com/pages/publications/9444229299

U2 - 10.1096/fj.03-1346fje

DO - 10.1096/fj.03-1346fje

M3 - Article

C2 - 15180968

AN - SCOPUS:9444229299

SN - 0892-6638

VL - 18

SP - 1315

EP - 1317

JO - FASEB Journal

JF - FASEB Journal

IS - 11

ER -

A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders

Access to Document

Other files and links

Cite this